Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
The report details the trend, potential and market size of Pirfenidone market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.
The first part (Chapter1-7) mainly covers the qualitative analysis of Pirfenidonemarket, defines the market attractiveness level of Pirfenidone market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.
The second part (Chapter8-12), based on the segmentation of Pirfenidone industry, describes the types of Pirfenidone market, the applications of major players and the market size, and deeply analyzes the current situation of the global Pirfenidone market and the development prospects and opportunities of Pirfenidone industry.
The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.
As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Pirfenidone market in Chapter 13.
By Player:
Koye Pharmaceuticals
Unimed Unihealth
Zydus Cadila
GNI Group
MSN Laboratories
Incepta Pharmaceuticals
Wockhardt
Lupin Ltd
Cipla
Genentech (Roche)
Beijing Continent
Shionogi
Glenmark Pharmaceuticals
By Type:
Tablet
Capsule
Other
By End-User:
Mild Idiopathic Pulmonary Fibrosis
Moderate Idiopathic Pulmonary Fibrosis
Other
By Geography:
-
United States
-
Europe
-
China
-
Japan
-
India
-
South Korea
TABLE OF CONTENT
1 Introduction
-
1.1 Market Definition
-
1.2 Market Segment Analysis
-
1.3 Market Size 2022
-
1.4 Pirfenidone Market Outlook: Forecast for 2022 - 2028
-
1.5 Pricing Analysis
2 Executive Summary
3 Pirfenidone Market Lineage Outlook
-
3.1 Parent Market Outlook
-
3.2 Related/Ancillary Market Outlook
-
3.3 Penetration & Growth Prospect Mapping, 2022
4 Market Analysis Tools: Porter's Five Forces
-
4.1 Supplier Power
-
4.2 Buyer Power
-
4.3 Substitution Threat
-
4.4 Threat of New Entrants
-
4.5 Competitive Rivalry
5 Pirfenidone Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)
-
5.1 Political/Legal Landscape
-
5.2 Economic Landscape
-
5.3 Social Landscape
-
5.4 Technology Landscape
6 Pirfenidone Market - Value Chain Analysis
-
6.1 Industry's Value Chain Analysis
-
6.2 Product Life Cycle
-
6.3 User Perspective Analysis
7 Region and Country-wise Pirfenidone Market Analysis and Outlook to 2022
-
7.1 Global Pirfenidone Consumption (2017-2022)
-
7.2 United States Pirfenidone Consumption (2017-2022)
-
7.3 Europe Pirfenidone Consumption (2017-2022)
-
7.4 China Pirfenidone Consumption (2017-2022)
-
7.5 Japan Pirfenidone Consumption (2017-2022)
-
7.6 India Pirfenidone Consumption (2017-2022)
-
7.7 South Korea Pirfenidone Consumption (2017-2022)
8 Region and Country-wise Pirfenidone Market Analysis and Outlook to 2028
-
8.1 Global Pirfenidone Consumption Forecast (2022-2028)
-
8.2 United States Pirfenidone Consumption Forecast (2022-2028)
-
8.3 Europe Pirfenidone Consumption Forecast (2022-2028)
-
8.4 China Pirfenidone Consumption Forecast (2022-2028)
-
8.5 Japan Pirfenidone Consumption Forecast (2022-2028)
-
8.6 India Pirfenidone Consumption Forecast (2022-2028)
-
8.7 South Korea Pirfenidone Consumption Forecast (2022-2028)
9 Global Pirfenidone Market Outlook by Types and Applications to 2022
-
9.1 Global Pirfenidone Consumption and Growth Rate by Type (2017-2022)
-
9.1.1 Global Tablet Consumption and Growth Rate (2017-2022)
-
9.1.2 Global Capsule Consumption and Growth Rate (2017-2022)
-
9.1.3 Global Other Consumption and Growth Rate (2017-2022)
-
9.2 Global Pirfenidone Consumption and Growth Rate by Application (2017-2022)
-
9.2.1 Global Mild Idiopathic Pulmonary Fibrosis Consumption and Growth Rate (2017-2022)
-
9.2.2 Global Moderate Idiopathic Pulmonary Fibrosis Consumption and Growth Rate (2017-2022)
-
9.2.3 Global Other Consumption and Growth Rate (2017-2022)
10 Global Pirfenidone Market Outlook by Types and Applications to 2028
-
10.1 Global Pirfenidone Consumption Forecast and Growth Rate by Type (2022-2028)
-
10.1.1 Global Tablet Consumption Forecast and Growth Rate (2022-2028)
-
10.1.2 Global Capsule Consumption Forecast and Growth Rate (2022-2028)
-
10.1.3 Global Other Consumption Forecast and Growth Rate (2022-2028)
-
10.2 Global Pirfenidone Consumption Forecast and Growth Rate by Application (2022-2028)
-
10.2.1 Global Mild Idiopathic Pulmonary Fibrosis Consumption Forecast and Growth Rate (2022-2028)
-
10.2.2 Global Moderate Idiopathic Pulmonary Fibrosis Consumption Forecast and Growth Rate (2022-2028)
-
10.2.3 Global Other Consumption Forecast and Growth Rate (2022-2028)
11 Global Pirfenidone Import and Export Analysis (Top 5 Countries)
-
11.1 Global Pirfenidone Import by Region (Top 5 Countries) (2017-2028)
-
11.2 Global Pirfenidone Export by Region (Top 5 Countries) (2017-2028)
12 Coronavirus Disease (COVID-19) Impact
-
12.1 Industry Impact Analysis
-
12.2 Pirfenidone Market Outlook to 2028 - COVID-19 Affected Forecasts
13 Competition Matrix
-
13.1 Target Markets
-
13.2 Comprehensive Analysis of Products in Competitive Markets
14 Global Pirfenidone Market Competitive Analysis
-
14.1 Koye Pharmaceuticals
-
14.1.1 Koye Pharmaceuticals Company Details
-
14.1.2 Koye Pharmaceuticals Pirfenidone Sales, Price, Value and Gross Profit (2017-2022)
-
14.1.3 Koye Pharmaceuticals Pirfenidone Product and Service
-
14.2 Unimed Unihealth
-
14.2.1 Unimed Unihealth Company Details
-
14.2.2 Unimed Unihealth Pirfenidone Sales, Price, Value and Gross Profit (2017-2022)
-
14.2.3 Unimed Unihealth Pirfenidone Product and Service
-
14.3 Zydus Cadila
-
14.3.1 Zydus Cadila Company Details
-
14.3.2 Zydus Cadila Pirfenidone Sales, Price, Value and Gross Profit (2017-2022)
-
14.3.3 Zydus Cadila Pirfenidone Product and Service
-
14.4 GNI Group
-
14.4.1 GNI Group Company Details
-
14.4.2 GNI Group Pirfenidone Sales, Price, Value and Gross Profit (2017-2022)
-
14.4.3 GNI Group Pirfenidone Product and Service
-
14.5 MSN Laboratories
-
14.5.1 MSN Laboratories Company Details
-
14.5.2 MSN Laboratories Pirfenidone Sales, Price, Value and Gross Profit (2017-2022)
-
14.5.3 MSN Laboratories Pirfenidone Product and Service
-
14.6 Incepta Pharmaceuticals
-
14.6.1 Incepta Pharmaceuticals Company Details
-
14.6.2 Incepta Pharmaceuticals Pirfenidone Sales, Price, Value and Gross Profit (2017-2022)
-
14.6.3 Incepta Pharmaceuticals Pirfenidone Product and Service
-
14.7 Wockhardt
-
14.7.1 Wockhardt Company Details
-
14.7.2 Wockhardt Pirfenidone Sales, Price, Value and Gross Profit (2017-2022)
-
14.7.3 Wockhardt Pirfenidone Product and Service
-
14.8 Lupin Ltd
-
14.8.1 Lupin Ltd Company Details
-
14.8.2 Lupin Ltd Pirfenidone Sales, Price, Value and Gross Profit (2017-2022)
-
14.8.3 Lupin Ltd Pirfenidone Product and Service
-
14.9 Cipla
-
14.9.1 Cipla Company Details
-
14.9.2 Cipla Pirfenidone Sales, Price, Value and Gross Profit (2017-2022)
-
14.9.3 Cipla Pirfenidone Product and Service
-
14.10 Genentech (Roche)
-
14.10.1 Genentech (Roche) Company Details
-
14.10.2 Genentech (Roche) Pirfenidone Sales, Price, Value and Gross Profit (2017-2022)
-
14.10.3 Genentech (Roche) Pirfenidone Product and Service
-
14.11 Beijing Continent
-
14.11.1 Beijing Continent Company Details
-
14.11.2 Beijing Continent Pirfenidone Sales, Price, Value and Gross Profit (2017-2022)
-
14.11.3 Beijing Continent Pirfenidone Product and Service
-
14.12 Shionogi
-
14.12.1 Shionogi Company Details
-
14.12.2 Shionogi Pirfenidone Sales, Price, Value and Gross Profit (2017-2022)
-
14.12.3 Shionogi Pirfenidone Product and Service
-
14.13 Glenmark Pharmaceuticals
-
14.13.1 Glenmark Pharmaceuticals Company Details
-
14.13.2 Glenmark Pharmaceuticals Pirfenidone Sales, Price, Value and Gross Profit (2017-2022)
-
14.13.3 Glenmark Pharmaceuticals Pirfenidone Product and Service
15 Appendix
TABLE OF CHARTS
-
Table Definition of Pirfenidone
-
Figure Pirfenidone Picture
-
Table Global Pirfenidone Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Pirfenidone Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Pirfenidone Market: Year-over-year Growth 2022 - 2028 (%)
-
Table Parent Market Analysis
-
Figure Parent Market Price
-
Table Related/Ancillary Market Outlook Analysis
-
Table Supplier Power Analysis
-
Table Buyer Power Analysis
-
Table Substitution Threat Analysis
-
Table Threat of New Entrants Analysis
-
Table Competitive Rivalry Analysis
-
Figure Global Pirfenidone Consumption by Country (2017-2022)
-
Figure United States Pirfenidone Consumption and Growth Rate (2017-2022)
-
Table Europe Pirfenidone Consumption and Growth Rate (2017-2022)
-
Figure China Pirfenidone Consumption and Growth Rate (2017-2022)
-
Figure Japan Pirfenidone Consumption and Growth Rate (2017-2022)
-
Figure India Pirfenidone Consumption and Growth Rate (2017-2022)
-
Figure South Korea Pirfenidone Consumption and Growth Rate (2017-2022)
-
Figure Global Pirfenidone Consumption Forecast by Country (2022-2028)
-
Figure United States Pirfenidone Consumption Forecast and Growth Rate (2022-2028)
-
Table Europe Pirfenidone Consumption Forecast and Growth Rate (2022-2028)
-
Figure China Pirfenidone Consumption Forecast and Growth Rate (2022-2028)
-
Figure Japan Pirfenidone Consumption Forecast and Growth Rate (2022-2028)
-
Figure India Pirfenidone Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Korea Pirfenidone Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Tablet Consumption and Growth Rate (2017-2022)
-
Figure Global Capsule Consumption and Growth Rate (2017-2022)
-
Figure Global Other Consumption and Growth Rate (2017-2022)
-
Figure Global Mild Idiopathic Pulmonary Fibrosis Consumption and Growth Rate (2017-2022)
-
Figure Global Moderate Idiopathic Pulmonary Fibrosis Consumption and Growth Rate (2017-2022)
-
Figure Global Other Consumption and Growth Rate (2017-2022)
-
Figure Global Tablet Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Capsule Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Other Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Mild Idiopathic Pulmonary Fibrosis Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Moderate Idiopathic Pulmonary Fibrosis Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Other Consumption Forecast and Growth Rate (2022-2028)
-
Table Global Pirfenidone Import by Region (Top 5 Countries) (2017-2028)
-
Table Global Pirfenidone Export by Region (Top 5 Countries) (2017-2028)
-
Table Koye Pharmaceuticals (Foundation Year, Company Profile and etc.)
-
Table Koye Pharmaceuticals Pirfenidone Sales, Price, Value and Gross Profit (2017-2022)
-
Table Koye Pharmaceuticals Pirfenidone Product and Service
-
Table Unimed Unihealth (Foundation Year, Company Profile and etc.)
-
Table Unimed Unihealth Pirfenidone Sales, Price, Value and Gross Profit (2017-2022)
-
Table Unimed Unihealth Pirfenidone Product and Service
-
Table Zydus Cadila (Foundation Year, Company Profile and etc.)
-
Table Zydus Cadila Pirfenidone Sales, Price, Value and Gross Profit (2017-2022)
-
Table Zydus Cadila Pirfenidone Product and Service
-
Table GNI Group (Foundation Year, Company Profile and etc.)
-
Table GNI Group Pirfenidone Sales, Price, Value and Gross Profit (2017-2022)
-
Table GNI Group Pirfenidone Product and Service
-
Table MSN Laboratories (Foundation Year, Company Profile and etc.)
-
Table MSN Laboratories Pirfenidone Sales, Price, Value and Gross Profit (2017-2022)
-
Table MSN Laboratories Pirfenidone Product and Service
-
Table Incepta Pharmaceuticals (Foundation Year, Company Profile and etc.)
-
Table Incepta Pharmaceuticals Pirfenidone Sales, Price, Value and Gross Profit (2017-2022)
-
Table Incepta Pharmaceuticals Pirfenidone Product and Service
-
Table Wockhardt (Foundation Year, Company Profile and etc.)
-
Table Wockhardt Pirfenidone Sales, Price, Value and Gross Profit (2017-2022)
-
Table Wockhardt Pirfenidone Product and Service
-
Table Lupin Ltd (Foundation Year, Company Profile and etc.)
-
Table Lupin Ltd Pirfenidone Sales, Price, Value and Gross Profit (2017-2022)
-
Table Lupin Ltd Pirfenidone Product and Service
-
Table Cipla (Foundation Year, Company Profile and etc.)
-
Table Cipla Pirfenidone Sales, Price, Value and Gross Profit (2017-2022)
-
Table Cipla Pirfenidone Product and Service
-
Table Genentech (Roche) (Foundation Year, Company Profile and etc.)
-
Table Genentech (Roche) Pirfenidone Sales, Price, Value and Gross Profit (2017-2022)
-
Table Genentech (Roche) Pirfenidone Product and Service
-
Table Beijing Continent (Foundation Year, Company Profile and etc.)
-
Table Beijing Continent Pirfenidone Sales, Price, Value and Gross Profit (2017-2022)
-
Table Beijing Continent Pirfenidone Product and Service
-
Table Shionogi (Foundation Year, Company Profile and etc.)
-
Table Shionogi Pirfenidone Sales, Price, Value and Gross Profit (2017-2022)
-
Table Shionogi Pirfenidone Product and Service
-
Table Glenmark Pharmaceuticals (Foundation Year, Company Profile and etc.)
-
Table Glenmark Pharmaceuticals Pirfenidone Sales, Price, Value and Gross Profit (2017-2022)
-
Table Glenmark Pharmaceuticals Pirfenidone Product and Service
-
